Consolidated statement of income
In € millions |
Note |
|
2014 |
|
2015 |
|||||
|
|
|
|
|
|
|||||
Continuing operations |
|
|
|
|
|
|||||
Revenue |
|
14,296 |
|
14,859 |
|
|||||
Cost of sales |
(8,676) |
|
(8,784) |
|
||||||
Gross profit |
|
|
5,620 |
|
6,075 |
|||||
Selling expenses |
(2,912) |
|
(3,021) |
|
||||||
General and administrative expenses |
(1,273) |
|
(1,245) |
|
||||||
Research and development expenses |
(363) |
|
(347) |
|
||||||
Incidentals |
(85) |
|
111 |
|
||||||
|
|
|
(4,633) |
|
(4,502) |
|||||
|
|
987 |
|
1,573 |
||||||
Financing income |
42 |
|
28 |
|
||||||
Financing expenses related to pensions |
(18) |
|
(13) |
|
||||||
Other financing expenses |
(180) |
|
(129) |
|
||||||
Results from associates and joint ventures |
21 |
|
17 |
|
||||||
Profit before tax |
|
|
852 |
|
1,476 |
|||||
Income tax |
|
(252) |
|
(416) |
||||||
Profit from continuing operations |
|
|
600 |
|
1,060 |
|||||
|
|
|
|
|
|
|||||
Discontinued operations |
|
|
|
|
|
|||||
Profit for the period from discontinued operations |
|
18 |
|
6 |
||||||
Profit for the period |
|
|
618 |
|
1,066 |
|||||
|
|
|
|
|
|
|||||
Attributable to |
|
|
|
|
|
|||||
Shareholders of the company |
|
|
546 |
|
979 |
|||||
Non-controlling interests |
|
|
72 |
|
87 |
|||||
Profit for the period |
|
|
618 |
|
1,066 |
|||||
|
|
|
|
|
|
|||||
Earnings per share, in € |
|
|
|
|
|
|||||
Continuing operations |
|
|
|
|
|
|||||
Basic |
|
2.16 |
|
3.93 |
||||||
Diluted |
|
2.15 |
|
3.90 |
||||||
Discontinued operations |
|
|
|
|
|
|||||
Basic |
|
0.07 |
|
0.02 |
||||||
Diluted |
|
0.07 |
|
0.02 |
||||||
Total operations |
|
|
|
|
|
|||||
Basic |
|
2.23 |
|
3.95 |
||||||
Diluted |
|
2.22 |
|
3.92 |
Operating income is defined in accordance with IFRS and includes the relevant incidental items.
Net income attributable to shareholders divided by the weighted average number of common shares outstanding during the year.